Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0001193125-26-468898

Chief Commercial Officer sold 448 shares at $7.27 ($3,257)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Powl Brian T. · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-11-19 Sale : show line 1 in the form 10b5-1 −448 $7.27 $3,257 112,817 D
Open-market sales · 448 sh · avg $7.27 · $3,257
Loading xslF345X06/ownership.xml…